TY - JOUR
T1 - Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus
AU - Peñacoba Toribio, Patricia
AU - Córica Albani, María Emilia
AU - Mayos Pérez, Mercedes
AU - Rodríguez de la Serna, Arturo
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus. We report the case of a patient with non-responding SLS (neither to glucocorticoids nor immunosupresors), who showed remarkable improvement after the onset of treatment with rituximab. Although there is a little evidence, treatment with rituximab could be proposed in SLS when classical treatment fails. © 2013 Elsevier España, S.L.
AB - Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus. We report the case of a patient with non-responding SLS (neither to glucocorticoids nor immunosupresors), who showed remarkable improvement after the onset of treatment with rituximab. Although there is a little evidence, treatment with rituximab could be proposed in SLS when classical treatment fails. © 2013 Elsevier España, S.L.
KW - Glucocorticoids
KW - Rituximab
KW - Shrinking lung syndrome
KW - Systemic lupus erythematosus
U2 - 10.1016/j.reuma.2013.09.003
DO - 10.1016/j.reuma.2013.09.003
M3 - Article
SN - 1699-258X
VL - 10
SP - 325
EP - 327
JO - Reumatologia Clinica
JF - Reumatologia Clinica
IS - 5
ER -